(US9S) WisdomTree SP500 3x Daily - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE00B8K7KM88

Leverage, Equity, Inverse, Short, ETF, Euro

Description: US9S WisdomTree SP500 3x Daily

The WisdomTree S&P 500 3x Daily Short EUR (XETRA:US9S) is an exchange-traded fund (ETF) designed to provide investors with a leveraged inverse exposure to the S&P 500 Index, with a 3x daily return. This means that for every 1% decline in the S&P 500 Index, the ETF is designed to return 3%, adjusted for the euro currency.

As a trading ETF, US9S is geared towards sophisticated investors seeking to capitalize on short-term market movements. The funds investment strategy involves using derivatives and other financial instruments to achieve its 3x daily inverse exposure. Given its leveraged nature, the ETF is not suitable for long-term investors or those who are risk-averse.

From a technical analysis perspective, the current price of 13.15 EUR is at its 52-week low, indicating a potential oversold condition. The short-term moving averages (SMA20: 15.51, SMA50: 17.44) suggest a downtrend, while the ATR (1.41 = 10.70%) indicates relatively high volatility. Considering these factors, a potential trading strategy could involve monitoring the ETFs price action for signs of a reversal or a bounce.

Fundamentally, the Assets Under Management (AUM) of 54.16M EUR indicate a relatively small but still viable fund. To forecast the ETFs future performance, we can analyze the S&P 500 Indexs current trends and the euro currencys influence. If the S&P 500 Index continues to decline, US9S is likely to benefit from its inverse exposure. However, if the index experiences a significant rally, the ETFs 3x leveraged inverse exposure could result in substantial losses.

Based on the technical and fundamental data, a potential forecast for US9S could be that it continues to be influenced by the S&P 500 Indexs short-term movements. If the index remains under pressure, US9S may experience a bounce or a consolidation phase, potentially targeting the SMA20 (15.51) or SMA50 (17.44) as a resistance level. Conversely, if the S&P 500 Index rallies, US9S may continue its downtrend, potentially testing new lows.

Additional Sources for US9S ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

US9S ETF Overview

Market Cap in USD 64m
Category Trading - Leveraged/Inverse Equity
TER 0.80%
IPO / Inception 2012-12-13

US9S ETF Ratings

Growth Rating -89.0
Fundamental -
Dividend Rating 0.0
Rel. Strength -49
Analysts -
Fair Price Momentum 6.34 EUR
Fair Price DCF -

US9S Dividends

Currently no dividends paid

US9S Growth Ratios

Growth Correlation 3m -97.7%
Growth Correlation 12m -63.8%
Growth Correlation 5y -91.9%
CAGR 5y -41.56%
CAGR/Max DD 5y -0.44
Sharpe Ratio 12m -1.31
Alpha -21.86
Beta -2.591
Volatility 30.98%
Current Volume 83.8k
Average Volume 20d 33.3k
Stop Loss 10.4 (-3.4%)
What is the price of US9S shares?
As of July 12, 2025, the stock is trading at EUR 10.77 with a total of 83,785 shares traded.
Over the past week, the price has changed by +0.98%, over one month by -13.94%, over three months by -44.60% and over the past year by -42.37%.
Is WisdomTree SP500 3x Daily a good stock to buy?
No, based on ValueRay´s Analyses, WisdomTree SP500 3x Daily (XETRA:US9S) is currently (July 2025) a stock to sell. It has a ValueRay Growth Rating of -89.04 and therefor a clear technical negative rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of US9S is around 6.34 EUR . This means that US9S is currently overvalued and has a potential downside of -41.13%.
Is US9S a buy, sell or hold?
WisdomTree SP500 3x Daily has no consensus analysts rating.
What are the forecasts for US9S share price target?
According to our own proprietary Forecast Model, US9S WisdomTree SP500 3x Daily will be worth about 6.9 in July 2026. The stock is currently trading at 10.77. This means that the stock has a potential downside of -36.4%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 6.9 -36.4%